from24/7 Wall St.6 days agoBusinessPrice Prediction: Why AbbVie's Post-Humira Pivot Makes It a Strong BuyAbbVie shows strong Q1 performance with raised guidance and positive momentum from Skyrizi and Rinvoq, leading to a buy rating.
from24/7 Wall St.2 weeks agoBusinessWhy I Can't Stop Buying AbbVie StockAbbVie remains a strong investment due to its reliable dividends, successful product replacements, and undervalued growth potential.
Businessfrom24/7 Wall St.6 days agoPrice Prediction: Why AbbVie's Post-Humira Pivot Makes It a Strong BuyAbbVie shows strong Q1 performance with raised guidance and positive momentum from Skyrizi and Rinvoq, leading to a buy rating.
Businessfrom24/7 Wall St.2 weeks agoWhy I Can't Stop Buying AbbVie StockAbbVie remains a strong investment due to its reliable dividends, successful product replacements, and undervalued growth potential.